Comparing CNAs across longitudinal metastases of this patient, we also identified progressive stepwise regional loss of chromosome 10 in relation to therapy (pre-, on-, and post-PD-1 inhibitor therapy), thus implicating this CNA in both tumor margin dynamics and overall disease progression (Supplementary Fig. 2). This evidence concerns the gene PDCD1 and neoplasm.